Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis.
Sousa-Batista, Ariane J; Escrivani-Oliveira, Douglas; Falcão, Camila Alves Bandeira; Philipon, Cintia Iana Monteiro da Silva; Rossi-Bergmann, Bartira.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-30012761
Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
Pharmacokinetics and pharmacodynamics of oleylphosphocholine in a hamster model of visceral leishmaniasis.
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Antileishmanial activity of meroditerpenoids from the macroalgae Cystoseira baccata.
Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
The Eukaryotic Elongation Factor 1 Alpha (eEF1α) from the Parasite Leishmania infantum Is Modified with the Immunomodulatory Substituent Phosphorylcholine (PC).
Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance.
Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.